Navigation Links
Echo Therapeutics Announces New Presentation Time at Rodman & Renshaw 2009 Annual Global Investment Conference
Date:9/9/2009

FRANKLIN, Mass., Sept. 9 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that it has rescheduled the Company's presentation at the Rodman & Renshaw 2009 Annual Global Investment Conference. Patrick T. Mooney, M.D., Chairman and Chief Executive Officer, will now present on Thursday, September 10, 2009 at 11:15am ET. The presentation will occur live and will be held at The New York Palace Hotel in New York, NY.

About Echo Therapeutics

Echo Therapeutics is focused on medical devices and specialty pharmaceuticals. Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System for transdermal drug delivery of a wide range of novel topical reformulations of widely-used, FDA-approved products.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's ongoing studies, including the efficacy of Echo's Symphony tCGM System and Prelude SkinPrep System, the failure of future development and preliminary marketing efforts related to Echo's Symphony tCGM System and Prelude SkinP
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Groups American subsidiary, Helsinn Therapeutics (U.S.) Inc.
2. Cell Therapeutics, Inc.s (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
3. Reportlinker Adds Autoimmune Disease Therapeutics Report
4. Reportlinker Adds Lung Cancer Therapeutics Report
5. Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report
6. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
7. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
8. Echo Therapeutics to Present at Rodman & Renshaw 2009 Annual Global Investment Conference
9. Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences
10. Selexis and NKT Therapeutics Enter Into Research Services Agreement
11. FDA Accepts to File Cell Therapeutics New Drug Application for Pixantrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- Scientists who used stem ... say their breakthrough could provide a new way to ... diseases. The team used human pluripotent stem cells ... the body -- to grow the functional miniature stomachs, ... a major cause of ulcers and stomach cancer. ...
(Date:10/30/2014)... Dennis Thompson HealthDay Reporter ... milk could be bad for your health, a new study ... milk can help strengthen bones and prevent osteoporosis. These benefits ... milk as part of a healthy diet. But this ... not protect men or women from bone fractures, and was ...
(Date:10/30/2014)... (HealthDay News) -- Eating a low-carb, high-fat diet could ... to new research. A review of five ... that focuses on foods like bacon, eggs, heavy cream, ... in adults whose condition doesn,t improve with medication. ... people with epilepsy whose seizures are not stopped by ...
(Date:10/30/2014)... News) -- A new vaccine that could help prevent ... by the U.S. Food and Drug Administration on Wednesday. ... ages of 10 and 25 from invasive meningococcal disease ... The bacteria can infect the bloodstream (sepsis) and ... It is a leading cause of bacterial meningitis, and ...
(Date:10/30/2014)... – A new standard of care for children facing ... multi-year study published in the latest edition of the ... research, led by John Wagner, Jr., M.D., director of ... University of Minnesota and a researcher in the Masonic ... with acute leukemia and myelodysplastic syndrome who received transplants ...
Breaking Medicine News(10 mins):Health News:Is Milk Your Friend or Foe? 2Health News:Is Milk Your Friend or Foe? 3Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3Health News:FDA Approves New Vaccine to Protect Against Meningitis 2Health News:Survival rates in pediatric umbilical cord transplants may indicate a new standard of care 2Health News:Survival rates in pediatric umbilical cord transplants may indicate a new standard of care 3
... was true for males tying the knot with younger females, study ... men seven to nine years their junior could be upping their ... with a significantly younger guy raises a woman,s risk of death ... 12 issue of Demography . , Not that marrying much ...
... years ago, scientists at Beth Israel Deaconess Medical Center ... the Akt molecular pathway, a popular target for cancer ... Akt1 was actively preventing cancer cells from ... was actually promoting breast cancer cell migration. And, indeed, ...
... 22q11 deletion syndrome (also known as DiGeorge syndrome) ... having an estimated incidence of at least one ... of severity but a multisystem impact, with symptoms ... endocrine abnormalities, cleft palate, gastrointestinal problems, and neuropsychiatric ...
... National ... was recently awarded certification from the Women’s Business Enterprise National Council (WBENC). ... San Diego, CA ... provider of water conservation and water management services , was ...
... ... extension option with Novation the leading health care supply contracting company for more than 25,000 ... and nearly 15,000 members of Provista, LLC. , ... Santa Clara (Vocus) May 14, 2010 -- Lumenis Ltd., a global leader ...
... out of ten patients who discontinued their overactive bladder (OAB) ... or they couldn,t tolerate it, according to research in the ... US researchers also discovered that smokers, men with enlarged prostates ... to stop taking prescription drugs for bladder problems. The ...
Cached Medicine News:Health News:Women Who Marry Younger Men May Die Earlier 2Health News:Study identifies 1 of the mechanisms behind breast cancer metastasis 2Health News:Without this protein, embryonic development halts 2Health News:National Water Services, Inc. Receives WBE Certification 2Health News:Lumenis Inc. Awarded a 3-year Dual Source Agreement with Novation 2Health News:Lumenis Inc. Awarded a 3-year Dual Source Agreement with Novation 3Health News:Lumenis Inc. Awarded a 3-year Dual Source Agreement with Novation 4Health News:Unmet expectations and smoking prove key factors in quitting bladder medication 2Health News:Unmet expectations and smoking prove key factors in quitting bladder medication 3
(Date:10/30/2014)... , Oct. 30, 2014 Stryker Orthopaedics, ... and Champions Tour, is rounding out its debut year ... in Scottsdale, AZ. This marks ... and Champions Tour that the brand has activated on-site ... to educate golf fans on the importance of joint ...
(Date:10/30/2014)... SHANGHAI , Oct. 30, 2014 WuXi PharmaTech ... open-access R&D capability and technology platform company serving the ... China and the ... a representative office in the Tel Aviv ... new office will promote WuXi,s broad platform of integrated ...
(Date:10/30/2014)... Boston Scientific Corporation (NYSE: BSX ... Suisse Annual Healthcare Conference on Tuesday, November 11, 2014 ... Brennan , executive vice president and chief financial officer, ... approximately 8:00 a.m. PT followed by a question and ... presentation and question and answer session will be available ...
Breaking Medicine Technology:Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 2Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 3Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 4WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2
... 11, 2011 U LURUInc.(NYSE Amex: ULU), ... a portfolio of wound management and oral care products, today ... (the "Exchange") advising ULURU that it is not in compliance ... under Section 1003 of the Exchange,s Company Guide (the "Company ...
... March 11, 2011 Mylan Inc. (Nasdaq: ... has upgraded the company,s credit ratings, including the "Corporate ... this action, Moody,s rating outlook is stable.   ... improving earnings trends accomplished through new product launches, a ...
Cached Medicine Technology:ULURU Inc. Receives Letter of Non-Compliance From NYSE Amex 2Moody's Upgrades Mylan 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: